Literature DB >> 29556291

Expression pattern of human SERPINE2 in a variety of human tumors.

Ying Yang1, Xiangke Xin1, Xing Fu1, Danmei Xu1,2.   

Abstract

Serine proteinase inhibitor, clade E member 2 (SERPINE2), also known as protease nexin-1 (PN-1), is a member of the serpin family. Despite several reported roles of SERPINE2 in tumor development the histological distribution of SERPINE2 and its expression levels in a large variety of tumors remains unclear. Through expressed sequence tag database analysis, immunohistochemical staining of tissue microarrays and a literature review, it was revealed that SERPINE2 expression varied according to growth stages and tissue types. SERPINE2 is differentially expressed in a number of tumors and their normal tissue counterparts. SERPINE2 is identified most abundantly in adenocarcinomas. SERPINE2 serves diverse roles in a variety of tumors and therefore may serve as a promising biomarker for tumor diagnosis and prognosis.

Entities:  

Keywords:  clade E member 2; differential expression; serine proteinase inhibitor; tumor biomarker; tumor microenvironment

Year:  2018        PMID: 29556291      PMCID: PMC5844088          DOI: 10.3892/ol.2018.7819

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  43 in total

1.  A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins.

Authors:  S Gloor; K Odink; J Guenther; H Nick; D Monard
Journal:  Cell       Date:  1986-12-05       Impact factor: 41.582

2.  Identification of a protease inhibitor produced by astrocytes that is structurally and functionally homologous to human protease nexin-I.

Authors:  D E Rosenblatt; C W Cotman; M Nieto-Sampedro; J W Rowe; D J Knauer
Journal:  Brain Res       Date:  1987-07-07       Impact factor: 3.252

3.  Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma.

Authors:  Chad M McKee; Danmei Xu; Yunhong Cao; Sheheryar Kabraji; Danny Allen; Veerle Kersemans; John Beech; Sean Smart; Freddie Hamdy; Adrian Ishkanian; Jenna Sykes; Melania Pintile; Michael Milosevic; Theodorus van der Kwast; Gaetano Zafarana; Varune Rohan Ramnarine; Igor Jurisica; Chad Mallof; Wan Lam; Robert G Bristow; Ruth J Muschel
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

4.  The expression and the role of protease nexin-1 on brain edema after intracerebral hemorrhage.

Authors:  He Wu; Ruibo Zhao; Jiping Qi; Yuwei Cong; Dandan Wang; Tao Liu; Yunhe Gu; Xiang Ban; Qi Huang
Journal:  J Neurol Sci       Date:  2008-04-28       Impact factor: 3.181

5.  Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach.

Authors:  Danmei Xu; Naoko Suenaga; Mariola J Edelmann; Rafael Fridman; Ruth J Muschel; Benedikt M Kessler
Journal:  Mol Cell Proteomics       Date:  2008-07-02       Impact factor: 5.911

Review 6.  Serpins for diagnosis and therapy in cancer.

Authors:  Donghang Zheng; Hao Chen; Jennifer Davids; Marsha Bryant; Alexandra Lucas
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2013-08

7.  SerpinE2 promotes multiple cell proliferation and drug resistance in osteosarcoma.

Authors:  Minzhi Mao; Wanchun Wang
Journal:  Mol Med Rep       Date:  2016-05-19       Impact factor: 2.952

8.  Protease Nexin-1 affects the migration and invasion of C6 glioma cells through the regulation of urokinase Plasminogen Activator and Matrix Metalloproteinase-9/2.

Authors:  Valentina Pagliara; Annagrazia Adornetto; Maria Mammì; Mariorosario Masullo; Daniela Sarnataro; Concetta Pietropaolo; Rosaria Arcone
Journal:  Biochim Biophys Acta       Date:  2014-07-27

9.  SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer.

Authors:  Akira Nagahara; Masashi Nakayama; Daizo Oka; Mutsumi Tsuchiya; Atsunari Kawashima; Masatoshi Mukai; Yasutomo Nakai; Hitoshi Takayama; Kazuo Nishimura; Yoshimasa Jo; Atsushi Nagai; Akihiko Okuyama; Norio Nonomura
Journal:  Biochem Biophys Res Commun       Date:  2009-12-24       Impact factor: 3.575

10.  SERPINE2 Inhibits IL-1α-Induced MMP-13 Expression in Human Chondrocytes: Involvement of ERK/NF-κB/AP-1 Pathways.

Authors:  Anna Santoro; Javier Conde; Morena Scotece; Vanessa Abella; Ana Lois; Veronica Lopez; Jesus Pino; Rodolfo Gomez; Juan J Gomez-Reino; Oreste Gualillo
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more
  5 in total

1.  Novel ELISA for the specific detection of protease NEXIN-1 in human biological samples.

Authors:  Laurence Venisse; Déborah François; Célina Madjène; Els Brouwers; Emmanuelle de Raucourt; Yacine Boulaftali; Paul Declerck; Véronique Arocas; Marie-Christine Bouton
Journal:  Res Pract Thromb Haemost       Date:  2022-07-19

2.  A Novel Acquired t(2;4)(q36.1;q24) with a Concurrent Submicroscopic del(4)(q23q24) in An Adult with Polycythemia Vera.

Authors:  Eigil Kjeldsen
Journal:  Cancers (Basel)       Date:  2018-06-25       Impact factor: 6.639

3.  Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance.

Authors:  Maria R Ward Rashidi; Pooja Mehta; Michael Bregenzer; Shreya Raghavan; Elyse M Fleck; Eric N Horst; Zainab Harissa; Visweswaran Ravikumar; Samuel Brady; Andrea Bild; Arvind Rao; Ronald J Buckanovich; Geeta Mehta
Journal:  Neoplasia       Date:  2019-07-09       Impact factor: 5.715

4.  High expression level of serpin peptidase inhibitor clade E member 2 is associated with poor prognosis in lung adenocarcinoma.

Authors:  Ryota Dokuni; Tatsuya Nagano; Naoe Jimbo; Hiroki Sato; Tatsunori Kiriu; Yuichiro Yasuda; Masatsugu Yamamoto; Motoko Tachihara; Kazuyuki Kobayashi; Yoshimasa Maniwa; Yoshihiro Nishimura
Journal:  Respir Res       Date:  2020-12-14

Review 5.  Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma.

Authors:  Enakshi Sivasudhan; Neil Blake; Zhi-Liang Lu; Jia Meng; Rong Rong
Journal:  Front Cell Dev Biol       Date:  2021-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.